Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE: Nitrous Oxide for TRD
NCT04957368Phase 4Completed
- Sponsor
- Unity Health Toronto
- Start
- Nov 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitrous oxide in treatment-resistant depression (TRD), sponsored by Unity Health Toronto. Started Nov 2021; status: completed.
02
Drugs
nitrous oxide
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT04957368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04957368.